The L80i Substitution in the Reverse Transcriptase Domain of the Hepatitis B Virus Polymerase is Associated with Lamivudine Resistance and Enhanced Viral Replication in Vitro.
From: Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia.
Antimicrobial agents and chemotherapy
- Publish Date: Jul 2007
- ISSN: 0066-4804
- Volume: 51
- Issue: 7
- Pages: 2285-92
- Medium: Print
- Language: English
- Citation (JAMA): Warner Nadia, Locarnini Stephen, Kuiper Michael, et al. The L80i Substitution in the Reverse Transcriptase Domain of the Hepatitis B Virus Polymerase is Associated with Lamivudine Resistance and Enhanced Viral Replication in Vitro.. Antimicrob. Agents Chemother. Jul 2007;51:2285-92
Abstract
Long-term lamivudine (LMV) treatment of chronic hepatitis B almost inevitably engenders viral resistance. Mutations that result in the replacement of the methionine at position 204 of the deoxynucleoside triphosphate-binding site of the hepatitis B virus (HBV) reverse transcriptase (rt) by isoleucine, valine, or (rarely) serine (rtM204I/V/S) confer high-level resistance to LMV but reduce replication efficiency. The subsequent selection or coselection of secondary mutations that partially restore replication efficiency is common and may influence drug resistance. Genotyping has shown that LMV treatment can select for HBV rtL80V/I mutants, but their prevalence and phenotype have not been documented. Analysis of a large sequence database revealed that rtL80V/I occurred almost exclusively in association with LMV resistance, and 85% of these isolates encoded rtL80I. Coselection of rtL80V/I occurred in 46% of isolates in which LMV resistance was attributable to rtM204I but only 9% of those in which resistance was attributable to rtM204V. Moreover, rtL80V/I did not occur in HBV genotype A isolates but occurred at similar frequencies in genotype B, C, and D isolates. In vitro phenotyping showed that although the rtL80I mutant by itself replicated less efficiently and was hypersensitive to LMV compared to the replication efficiency and sensitivity of its wild-type parent, the presence of rtL80I enhanced the replication efficiency of rt204I/V mutants without significantly affecting LMV resistance. Molecular modeling revealed that rt80 does not interact directly with the enzyme’s substrates. Collectively, these results suggest that coselection of rtL80V/I and rtM204I/V occurs because the former compensates for the loss of replication efficiency associated with the acquisition of LMV resistance, particularly in the case of rtM204I.
Mesh Headings (Keywords): Amino Acid Motifs, Amino Acid Sequence, Amino Acid Substitution, Binding Sites, Carcinoma, Hepatocellular, Cell Line, Tumor, Conserved Sequence, DNA-Directed DNA Polymerase, Drug Resistance, Viral, Hepatitis B virus, Humans, Lamivudine, Liver Neoplasms, Models, Molecular, Molecular Sequence Data, Mutagenesis, Site-Directed, Protein Structure, Secondary, Protein Structure, Tertiary, Reverse Transcriptase Inhibitors, Sequence Homology, Amino Acid, Virus Replication
Check for Full Text / PubMed Unique Identifier (PMID): 17438047
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.